je.st
news
Cidara Therapeutics Inc (CDTX) Rating Lowered to Hold at Zacks Investment Research
2016-03-25 03:28:33| Biotech - Topix.net
According to Zacks, "Cidara Therapeutics, Inc. is a biotechnology company. The company is focused on the discovery, development and commercialization of novel anti-infectives.
Tags: research
rating
hold
investment
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||